Sartorius Ag (NASDAQ:SARTF) was downgraded by Zacks Investment Research from a “hold” rating to a “sell” rating in a research note issued to investors on Wednesday.
According to Zacks, “Sartorius AG is a pharmaceutical and laboratory equipment supplier. The company manufactures equipment for biomolecular and microbial separations, cell culture, concentration, fermentation and purification. Sartorius AG is headquartered in Goettingen, Germany. “
Separately, DZ Bank AG restated a “sell” rating on shares of Sartorius Ag in a research report on Friday, July 21st.
Sartorius Ag (NASDAQ SARTF) traded up 0.0000% on Wednesday, hitting $94.0688. Sartorius Ag has a 52-week low of $75.00 and a 52-week high of $96.00. The company has a market cap of $6.43 billion and a P/E ratio of 52.0004.
Receive News & Ratings for Sartorius Ag Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sartorius Ag and related companies with MarketBeat.com's FREE daily email newsletter.